Sponsored Symposia

Wednesday, November 8, 2023

12:45-1:30 pm

Janssen industry sponsored symposium

Supported by Janssen-Cilag

12:45–12:50 pm
Introduction
Prof. H. Abken (RCI – University of Regensburg, Regensburg, Germany)

12:50–1:00 pm
The power of the immune control of cancer: CARs, antibodies & inhibitors
Prof. H. Abken (RCI – University of Regensburg, Regensburg, Germany)

1:00-1:10 pm
Immuno-oncology and GU cancer - A fairy or reality?
Prof. G. von Amsberg (University Medical Center Hamburg-Eppendorf, Hamburg, Germany)

1:10-1:20 pm
Current immunotherapy strategies in hematologic malignancies with a focus on multiple myeloma
Prof. L. Hansmann (Charité – University Medicine Berlin, Berlin, Germany)

1:20-1:30 pm
Discussion and summary
Prof. H. Abken, Prof. G. von Amsberg, Prof. L. Hansmann

 

4:15-5:00 pm

Kite industry sponsored symposium: Evolving landscape of CAR T-cell therapies

Supported by Kite

4:15–4:20 pm
Welcome & introduction
Chair: Dr. Vladan Vucinic (University Medicine Leipzig, Leipzig, Germany)

4:20–4:35 pm
Predicting response to CAR T-cell therapy: Biomarkers and prognostic factors
PD Dr. Stephan Fricke (Clinical Center Chemnitz, Chemnitz / Fraunhofer IZI, Leipzig, Germany)

4:35-4:50 pm
Bringing CAR T-cell therapy into clinical practice: Real world experience
PD Dr. Ulf Schnetzke (University Medicine Jena, Jena, Germany)

4:50-5:00 pm
Panel discussion and Q&A
Chair: Dr. Vladan Vucinic (University Medicine Leipzig, Leipzig, Germany)